Search research articles
Contact Us
Filters
Showing results (31-40 of 184) with videos related to
Page
of 19
Sort By:
Neuroendocrinology
|
February 1, 1994
Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat
J Weidenfeld, S Feldman, R Mechoulam
Science'S STKE : Signal Transduction Knowledge Environment
|
April 25, 2002
Endocannabinoids and neuroprotection
R Mechoulam, M Spatz, E Shohami
Science (New York, N.Y.)
|
June 23, 1978
Identification of a C-Glucuronide of Dgr6-Tetrahydrocannabinol as a Mouse Liver Conjugate in vivo
S Levy, B Yagen, R Mechoulam
Pharmacology, Biochemistry, and Behavior
|
February 26, 1998
Biphasic effects of anandamide
E Sulcova, R Mechoulam, E Fride
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1988
Pharmacokinetics of cannabidiol in dogs
E Samara, M Bialer, R Mechoulam
Science (New York, N.Y.)
|
June 23, 1978
Identification of a C-glucuronide of delta6- tetrahydrocannabinol as a mouse liver conjugate in vivo
S Levy, B Yagen, R Mechoulam
Brain Research
|
September 17, 1993
Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211
V Nadler, R Mechoulam, M Sokolovsky
Neuroscience Letters
|
November 12, 1993
The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain
V Nadler, R Mechoulam, M Sokolovsky
Neurotoxicology
|
December 9, 2009
Endocannabinoid signaling in neurotoxicity and neuroprotection
C Pope, R Mechoulam, L Parsons
European Journal of Pharmacology
|
September 30, 2000
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice
R Gallily, A Breuer, R Mechoulam
Page
of 19
Search research articles
Search
Showing results (31-40 of 184) with videos related to
Sort By:
Page
of 19
Neuroendocrinology
|
February 1, 1994
Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat
J Weidenfeld, S Feldman, R Mechoulam
Science'S STKE : Signal Transduction Knowledge Environment
|
April 25, 2002
Endocannabinoids and neuroprotection
R Mechoulam, M Spatz, E Shohami
Science (New York, N.Y.)
|
June 23, 1978
Identification of a C-Glucuronide of Dgr6-Tetrahydrocannabinol as a Mouse Liver Conjugate in vivo
S Levy, B Yagen, R Mechoulam
Pharmacology, Biochemistry, and Behavior
|
February 26, 1998
Biphasic effects of anandamide
E Sulcova, R Mechoulam, E Fride
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1988
Pharmacokinetics of cannabidiol in dogs
E Samara, M Bialer, R Mechoulam
Science (New York, N.Y.)
|
June 23, 1978
Identification of a C-glucuronide of delta6- tetrahydrocannabinol as a mouse liver conjugate in vivo
S Levy, B Yagen, R Mechoulam
Brain Research
|
September 17, 1993
Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211
V Nadler, R Mechoulam, M Sokolovsky
Neuroscience Letters
|
November 12, 1993
The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-delta 6- tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates N-methyl-D-aspartate receptor-mediated neurotoxicity in primary cultures of rat forebrain
V Nadler, R Mechoulam, M Sokolovsky
Neurotoxicology
|
December 9, 2009
Endocannabinoid signaling in neurotoxicity and neuroprotection
C Pope, R Mechoulam, L Parsons
European Journal of Pharmacology
|
September 30, 2000
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice
R Gallily, A Breuer, R Mechoulam
Page
of 19